DALLAS, November 2, 2017 – Kiran Musunuru, M.D., Ph.D., M.P.H., is the new editor-in-chief of Circulation: Cardiovascular Genetics, one of 12 American Heart Association (AHA) scientific journals.

Circulation: Cardiovascular Genetics, launched in October 2008, publishes articles on the genetic basis and influences of cardiovascular disorders. The journal further covers research from the fields of genomics, epigenomics, metabolomics, proteomics, systems biology and precision medicine. Articles published in this journal advance the improvement of methods for prevention, screening and management of cardiovascular disease. As Musunuru assumes the editorship, in 2018 the journal will be also taking on a new name, Circulation: Genomic and Precision Medicine, to reflect an expanded scope.

Musunuru, associate professor of cardiovascular medicine and genetics at the Perelman School of Medicine at the University of Pennsylvania, is an expert on the genetic basis of cardiovascular and other human diseases and has been in the field for nearly 20 years. In addition to his research work, Musunuru is a practicing cardiologist and teaches undergraduates, medical students and residents.

Musunuru is an active member of the American Heart Association (AHA) community. He currently serves on the leadership committees of AHA’s Clinical Cardiology Council and Functional Genomics and Translational Biology Council, serves on the AHA’s Science and Clinical Education Lifelong Learning committee, has previously served on a variety of AHA committees, and recently received the AHA’s Award of Meritorious Achievement. Musunuru has received numerous recognitions for his scientific research, including the Presidential Early Career Award for Scientists and Engineers from the White House in 2016.

“Dr. Musunuru’s experience and leadership in genetics brings enthusiasm and commitment to his new post as editor of Circulation: Cardiovascular Genetics,” said Mark Estes, M.D., Chair of the AHA’s Scientific Publishing Committee and director and professor of medicine at the New England Cardiac Arrhythmia Center at Tufts University School of Medicine.

Additional Resources:


Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at www.heart.org/corporatefunding.

About the American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.

For Media Inquiries and AHA/ASA Spokesperson Perspective: 214-706-1173

Carrie Thacker: 214-706-1665; carrie.thacker@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and strokeassociation.org